How Often to Test Biomarkers: Intervals That Make Sense

The Two Constraints

Biological timescale. How long the marker takes to reflect a genuine change. HbA1c integrates roughly three months of glycaemia. The omega-3 index reflects three to four months of intake, set by red cell lifespan. Bone density changes over 12 to 18 months. Sleep regularity changes within days.

Measurement variability. The combination of analytical variation in the assay and biological variation within the same person between draws. For some markers this is small; for others it is large enough to swamp real change. Triglycerides vary substantially between draws in the same person; apoB much less.

The useful concept is the reference change value: how large a difference between two measurements must be before it is unlikely to be noise. For markers with high variability this is a large number, which is why single-value comparisons mislead.

The practical rule that follows: for any marker, repeat at an interval where the expected biological change exceeds the measurement variability. For most blood markers that is three months at the shortest and often longer.

Intervals by Marker

Two rows deserve emphasis. The coronary calcium score is not a monitoring tool: repeating it to see whether a statin is working is not a validated use, since calcification can increase on therapy as plaque stabilises. And Lp(a) genuinely needs measuring only once, which is unusual and worth taking advantage of.

When to Test More Often

Shorter intervals are justified in specific circumstances rather than as a general practice.

After starting or changing a medication that affects a marker: 6 to 12 weeks for lipids, 6 to 8 weeks for thyroid after a dose change, and per clinical guidance for anything requiring safety monitoring.

When correcting a nutrient shortfall: 3 months, to confirm the correction worked and adjust the dose.

During a deliberate intervention with a defined observation window: baseline and 3 months, which is the Insight Protocol structure.

When a result is unexpected: repeat before acting, ideally with attention to whatever might have confounded it.

During pregnancy, active illness or a clinical condition requiring monitoring, per clinical guidance.

On a new medication with interaction potential, where a baseline and follow-up are warranted.

What does not justify shorter intervals: curiosity, a subscription that includes quarterly testing, or the belief that more data is better. More frequent testing of a slow marker produces a sequence of noise that invites unnecessary changes.

The Costs of Testing Too Often

These are real rather than rhetorical, and worth naming.

False signals. Any marker will drift outside its range occasionally by chance, and the more often you measure, the more often that happens. Each occurrence invites investigation or a protocol change that the underlying biology did not warrant.

Attribution errors. A marker that moves for reasons of variability gets attributed to whatever changed recently, which reinforces beliefs about interventions that did nothing.

Cascade investigation. An incidental abnormality leads to further tests, imaging and occasionally procedures, each with its own risk. This is well documented in imaging and applies to laboratory testing too.

Anxiety. Frequent measurement of markers that fluctuate produces a state of chronic mild alarm that is itself unhelpful.

Cost and displacement. Money spent on quarterly panels is not spent on the things that would help more, and time spent reviewing dashboards is not spent training or sleeping.

Protocol churn. Reacting to noise produces a stack that changes constantly, which makes attribution impossible and defeats the purpose of measuring.

A Sensible Annual Rhythm

Once a year: the core panel, drawn under consistent conditions at a similar time of year. Same laboratory, similar fasting and activity state.

Quarterly: the functional measures, grip strength, sit-to-stand, fitness estimate, plus a week of home blood pressure twice a year.

Monthly: waist circumference. Weekly: a glance at sleep regularity and resting heart rate.

Three months after any deliberate change: the specific markers that change was meant to move, and nothing else.

Once in a lifetime: lipoprotein(a), and family history properly established.

Per guideline: DEXA, age-appropriate cancer screening, audiogram from midlife, dermatological examination if at risk.

Testing at the same point in the year matters more than people expect, since several markers vary seasonally, vitamin D most dramatically at higher latitudes. Comparing a February vitamin D to an August one measures the season.

The Underlying Principle

The purpose of a repeat measurement is to answer a question, and if no question has been posed, the repeat has no purpose.

Before ordering a test, the useful discipline is to state what result would change what you do. If a marker is normal, you are stable, and nothing has changed, an annual repeat maintains the record and a quarterly repeat answers nothing. If you have changed something specific, the repeat answers whether it worked, and the interval should match the marker's timescale.

This also explains why continuity beats intensity in this domain. Ten annual panels drawn under consistent conditions are worth considerably more than forty panels drawn quarterly under varying conditions, because the first produces an interpretable trend and the second produces a scatter.

The unglamorous conclusion: test less often than the market suggests, more consistently than most people manage, and keep the results somewhere you can compare them. That combination extracts more from measurement than any additional analyte.